Skip to content

Reproducibility of Glucose Fluctuations by Standardized Exercise for Patients With Type 1 Diabetes - a Method Study Based on Continuous Glucose Monitoring

Reproducibility of Glucose Fluctuations by Standardized Exercise for Patients With Type 1 Diabetes - a Method Study Based on Continuous Glucose Monitoring

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02942069
Enrollment
12
Registered
2016-10-21
Start date
2016-12-31
Completion date
2019-02-28
Last updated
2019-03-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Continuous Glucose Monitoring, Diabetes Mellitus, Type 1, Exercise

Brief summary

The purpose of this project is to investigate whether the glucose response in type 1 diabetes patients measured using Continuous Glucose Monitoring measurement is reproducible in repeated standardized test sessions that include physical activity.

Interventions

BEHAVIORALBlood glucose measured using CGM during standardized physical activity

Standardized exercise on bicycle at 70% of the participants work capacity for ½ hour.

Sponsors

Nordsjaellands Hospital
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
18 Years to 60 Years
Healthy volunteers
No

Inclusion criteria

* Type 1 diabetes with a diabetes duration of at least 2 years * age 18-60 years (inclusive) * given informed consent * exercises (at least 30 minutes intentional exercise where participants feel exhausted) one or more times a week * participants agree to use CGM correctly

Exclusion criteria

* pregnancy * exercising at a high level (five or more times a week with high intensity) * treatment with prednisolone or less than a month ago contestant has been treated with prednisolone * treatment with beta blockers * Abuse of alcohol / drugs

Design outcomes

Primary

MeasureTime frameDescription
Blood glucose response measured with CGM3 identical testing sessions throughout 3 weeksThe participants will be tested on the research facility on a hospital in Denmark

Countries

Denmark

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026